NCT07536542 Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease
| NCT ID | NCT07536542 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara University |
| Condition | Parkinson Disease (PD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 38 participants |
| Start Date | 2026-04-24 |
| Primary Completion | 2026-07-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 38 participants in total. It began in 2026-04-24 with a primary completion date of 2026-07-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate the effects of dual-task training on upper extremity function and muscle thickness in individuals with Parkinson's disease. The main questions it aims to answer are: Does dual-task training improve upper extremity function in individuals with Parkinson's disease? Does dual-task training lead to changes in upper extremity muscle thickness measured by ultrasonography? Researchers will compare a dual-task training group with a control group receiving routine care to determine whether 8 weeks of dual-task training results in greater improvements in upper extremity outco Participants will: complete baseline and post-intervention assessments of upper extremity function, muscle thickness, grip strength, and pinch strength be assigned to either a control group or a dual-task training group receive dual-task training 3 days per week for 8 weeks if assigned to the intervention group
Eligibility Criteria
Inclusion Criteria: * Diagnosis of idiopathic Parkinson's disease confirmed by a neurologist * Modified Hoehn and Yahr stage 2 to 3 * No medication or dosage change within the last 6 months * Cognitive capacity sufficient to understand and follow instructions, defined as Montreal Cognitive Assessment score ≥21 * Voluntary participation with written informed consent Exclusion Criteria: * Atypical or secondary parkinsonism * Advanced orthopedic condition affecting the upper extremity * Surgery, trauma, or immobilization involving the upper extremity within the last 6 months * Wound or dermatological condition preventing upper extremity ultrasonographic evaluation * Severe visual or hearing loss * Severe depression, psychosis, or communication difficulty * Any additional health problem preventing regular participation in the study
Contact & Investigator
Büşra Seçkinoğulları Korkusuz
PRINCIPAL INVESTIGATOR
Ankara University
Frequently Asked Questions
Who can join the NCT07536542 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Parkinson Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07536542 currently recruiting?
Yes, NCT07536542 is actively recruiting participants. Contact the research team at bskorkusuz@ankara.edu.tr for enrollment information.
Where is the NCT07536542 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07536542 clinical trial?
NCT07536542 is sponsored by Ankara University. The principal investigator is Büşra Seçkinoğulları Korkusuz at Ankara University. The trial plans to enroll 38 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.